Critical insights in India: factors linked to ICU admission and mortality in influenza cases
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20252121Keywords:
Epidemiological factors, Causality, Retrospective study, Respiratory tract infections, Secondary infectionAbstract
Background: Influenza remains a major public health concern globally, causing significant morbidity and mortality. Severe influenza infections are often complicated by pulmonary co-infections and may require intensive care, but data on risk factors contributing to worse outcomes in Indian settings are limited. The objective of the study was to identify risk factors associated with severe influenza outcomes and to assess the prevalence of pulmonary co-infections among hospitalized influenza patients.
Methods: A retrospective cross-sectional study design was opted. Three-years data from 625 laboratory-confirmed influenza patients was analysed. Regression models were used to identify predictors of ICU admission and mortality.
Results: Most patients aged above 18 years and there was higher male population. Influenza A/H1N1 was the most common subtype (66.88%). 39.1% patients required ICU admission and 33.4% had mortality. Influenza A/H1N1 infection, age >18 years, female gender, obesity (BMI >30 kg/m²), respiratory failure, viral pneumonia, renal insufficiency, stroke, diabetes mellitus, and presence of dyspnea or fever were associated with increased odds of ICU admission. Independent risk factors for mortality included Influenza A/H1N1 infection, age >65 years, obesity, hypertension, hepatic disease, respiratory failure, bacterial co-infections, and prior use of immunosuppressants or antibiotics after admission. Pulmonary co-infections were identified in 29.92% (viral) and 24.96% (bacterial) of cases, with Klebsiella pneumoniae and RSV being the predominant pathogens.
Conclusions: Severe influenza outcomes were significantly associated with specific host factors, viral subtypes, and secondary infections. Targeted prevention strategies, early intervention, and improved vaccination coverage, especially among high-risk groups, may reduce the burden of severe influenza-related illness and mortality in India.
Metrics
References
World Health Organization. (2020). Influenza (Seasonal). World Health Organization. Available at: https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal). Accessed on 3 March 2025.
Ministry of Health and Family Welfare, Government of India. 2020. Guidelines for Management of Influenza and Pneumonia. Available at: https://www.mohfw.gov.in. Accessed on 3 March 2025.
Beumer MC, Koch RM, Van Beuningen D, OudeLashof AM, Van de Veerdonk FL, Kolwijck E, et al. Influenza virus and factors that are associated with ICU admission, pulmonary co-infections and ICU mortality. J Critical Care. 2019;50:59-65. DOI: https://doi.org/10.1016/j.jcrc.2018.11.013
Martin-Loeches I, M JS, Vincent JL, Alvarez-Lerma F, Bos LD, Sole-Violan J, et al. Increased incidence of co-infection in critically ill patients with influenza. Intensive Care Med. 2017;43(1):48-58. DOI: https://doi.org/10.1007/s00134-016-4578-y
Koch RM, Kox M, de Jonge MI, van der Hoeven JG, Ferwerda G, Pickkers P: Patterns in bacterial- and viral-induced immunosuppression and secondary infections in the ICU. Shock. 2016. DOI: https://doi.org/10.1097/SHK.0000000000000731
van deVeerdonkFL, Kolwijck E, Lestrade PP, Hodiamont CJ, Rijnders BJ, van Paassen J, et al. Influenza-Associated Aspergillosis in Critically Ill patients. Am J Respir Crit Care Med. 2017;196(4):524–7. DOI: https://doi.org/10.1164/rccm.201612-2540LE
Crum-Cianflone NF. Invasive aspergillosis associated with severe influenza infec tions. OPEN FORUM Infect Dis. 2016;3(3):ofw171. DOI: https://doi.org/10.1093/ofid/ofw171
Ajma lS, Mahmood M, Abu Saleh O, Larson J, Sohail MR. Invasive fungal infections associated with prior respiratory Infection. 2018;46(4):555-558. DOI: https://doi.org/10.1007/s15010-018-1138-0
Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018;391(10127):1285-300. DOI: https://doi.org/10.1016/S0140-6736(17)33293-2
GBD 2017 Influenza Collaborators. Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2019;7(1):69-89. DOI: https://doi.org/10.1016/S2213-2600(18)30496-X
Deva A, Madhavi B, Kumar Nagaiah S, Pm B. Prevalence and Characteristics of Influenza Cases From 2017 to 2019 at a Tertiary Care Teaching Hospital in Karnataka. Cureus. 2024;16(1):e53205. DOI: https://doi.org/10.7759/cureus.53205
Centers for Disease Control and Prevention. 2021. Flu Symptoms & Complications. Available at: https://www.cdc.gov/flu/symptoms/symptoms.htm. Accessed on 3 March 2025.
Narayan VV, Iuliano AD, Roguski K, Haldar P, Saha S, Sreenivas V, et al. Evaluation of data sources and approaches for estimation of influenza-associated mortality in India. Influenza Other Respir Viruses. 2018;12:72-80. DOI: https://doi.org/10.1111/irv.12493
Narayan VV, Iuliano AD, Roguski K, Bhardwaj R, Chadha M, Saha S, et al. Burden of influenza-associated respiratory and circulatory mortality in India, 2010-2013. J Glob Health. 2020;10(1):010402. DOI: https://doi.org/10.7189/jogh.10.010402
Jamoussi A, Ayed S, Merhabene T, Doghri H, Ben Khelil J, Besbes M. Severe influenza A in a Tunisian ICU sentinel SARI centre: Epidemiological and clinical features. Plos one. 2022;17(7):e0270814. DOI: https://doi.org/10.1371/journal.pone.0270814
El Guerche-Séblain C, Etcheto A, Parmentier F, Afshar M, E. Macias A, Puentes E, et al. Hospital admissions with influenza and impact of age and comorbidities on severe clinical outcomes in Brazil and Mexico. PLoS One. 2022;17(11):e0273837. DOI: https://doi.org/10.1371/journal.pone.0273837
Caini S, Kroneman M, Wiegers T, El Guerche‐Séblain C, Paget J. Clinical characteristics and severity of influenza infections by virus type, subtype, and lineage: a systematic literature review. Influenza and other respiratory viruses. 2018;12(6):780-92. DOI: https://doi.org/10.1111/irv.12575
Yi G, de Kraker ME, Buetti N, Zhong X, Li J, Yuan Z, et al. Risk factors for in-hospital mortality and secondary bacterial pneumonia among hospitalized adult patients with community-acquired influenza: a large retrospective cohort study. Antimicrobial Resistance Infection Control. 2023;12(1):25. DOI: https://doi.org/10.1186/s13756-023-01234-y
Zhang ZX, Kyaw WM, Ho HJ, Tay MZ, Huang H, Hein AA, et al. Seasonal influenza-associated intensive care unit admission and death in tropical Singapore, 2011-2015. J Clin Virol. 2019;117:73-9. DOI: https://doi.org/10.1016/j.jcv.2019.06.005
Wæhre T, Tunheim G, Bodin JE, Laake I, Kvale D, Kran AM, et al. Clinical characteristics and outcomes in hospitalized adult influenza patients: an observational study from Norway 2014–2018. Infectious Diseases. 2022;54(5):367-77. DOI: https://doi.org/10.1080/23744235.2021.2022196
Coleman BL, Fadel SA, Fitzpatrick T, Thomas SM. Risk factors for serious outcomes associated with influenza illness in high‐versus low‐and middle‐income countries: systematic literature review and meta‐analysis. Influenza Respirat Viruses. 2018;12(1):22-9. DOI: https://doi.org/10.1111/irv.12504
Mertz D, Lo CK, Lytvyn L, Ortiz JR, Loeb M. Pregnancy as a risk factor for severe influenza infection: an individual participant data meta-analysis. BMC Infect Dis. 2019;19:1-0. DOI: https://doi.org/10.1186/s12879-019-4318-3
Avni T, Babich T, Nir A, Yahav D, Shaked H, Sorek N, et al. Comparison of clinical outcomes of influenza A and B at the 2017–2018 influenza season: a cohort study. Euro J Clin Microbiol Infect Dis. 2020;39:1109-14. DOI: https://doi.org/10.1007/s10096-020-03822-x
Alosaimi B, Naeem A, Hamed ME, Alkadi HS, Alanazi T, Al Rehily SS, et al. Influenza co-infection associated with severity and mortality in COVID-19 patients. Virol J. 2021;18(1):127. DOI: https://doi.org/10.1186/s12985-021-01594-0
Al-Dorzi HM, Alsafwani ZA, Alsalahi E, Aljulayfi AS, Alshaer R, Alanazi S, et al. Patients with influenza admitted to a tertiary-care hospital in Riyadh between 2018 and 2022: characteristics, outcomes and factors associated with ICU admission and mortality. BMC Pulmonary Med. 2024;24(1):464. DOI: https://doi.org/10.1186/s12890-024-03281-6
Yang K, Zhang N, Gao C, Qin H, Wang A, Song L. Risk factors for hospital-acquired influenza A and patient characteristics: a matched case-control study. BMC Infect Dis. 2020;20:1-0. DOI: https://doi.org/10.1186/s12879-020-05580-9
Bai Y, Guo Y, Gu L. Additional risk factors improve mortality prediction for patients hospitalized with influenza pneumonia: a retrospective, single-center case–control study. BMC Pulmonary Med. 2023;23(1):19. DOI: https://doi.org/10.1186/s12890-022-02283-6
Shirey KA, Perkins DJ, Lai W, Zhang W, Vogel SN. Influenza “trains” the host for enhanced susceptibility to secondary bacterial infection. MBio. 2019. DOI: https://doi.org/10.1128/mBio.00810-19
Shah NS, Greenberg JA, McNulty MC, Gregg KS, Riddell IV J, Mangino JE, et al. Bacterial and viral co-infections complicating severe influenza: incidence and impact among 507 US patients, 2013–14. J Clin Virol. 2016;80:12-9. DOI: https://doi.org/10.1016/j.jcv.2016.04.008
Alexander V, Paul GJ, Zachariah A, Mathuram AJ. A hospital-based nonconcurrent cohort study on factors associated with in-hospital mortality in patients with laboratory confirmed influenza. J Global Infect Dis. 2020;12(4):208-13. DOI: https://doi.org/10.4103/jgid.jgid_45_20
Gao Y, Guyatt G, Uyeki TM, Liu M, Chen Y, Zhao Y, et al. Antivirals for treatment of severe influenza: a systematic review and network meta-analysis of randomised controlled trials. The Lancet. 2024;404(10454):753-63. DOI: https://doi.org/10.1016/S0140-6736(24)01307-2
Arriola C, Garg S, Anderson EJ, Ryan PA, George A, Zansky SM, et al. Influenza Vaccination Modifies Disease Severity Among Community-dwelling Adults Hospitalized With Influenza. Clin Infect Dis. 2017;65(8):1289-97. DOI: https://doi.org/10.1093/cid/cix468
Nichols MK, Andrew MK, Hatchette TF, Ambrose A, Boivin G, Bowie W, et al. Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: A pooled analysis from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS Network). Vaccine. 2018;36(16):2166-75. DOI: https://doi.org/10.1016/j.vaccine.2018.02.093
Thompson MG, Pierse N, Sue Huang Q, Prasad N, Duque J, Claire Newbern E, et al. Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012-2015. Vaccine. 2018;36(39):5916-25. DOI: https://doi.org/10.1016/j.vaccine.2018.07.028
Rizvi AA, Singh A. Vaccination coverage among older adults: a population-based study in India. Bull World Health Organ. 2022;100(6):375-84. DOI: https://doi.org/10.2471/BLT.21.287390
Downloads
Published
How to Cite
Issue
Section
